Randomized Comparison of Endocardial Versus Epicardial - From the Coronary Sinus - Left Ventricular Pacing for Resynchronization in Heart Failure.
EPI-ENDO
2 other identifiers
interventional
6
1 country
1
Brief Summary
Biventricular pacing is a validated treatment for patients suffering from heart failure resistant to medical treatment. However, up to 30% of the patients are non responsive to this strategy using the coronary sinus approach to pace the Left Ventricle (LV). It has been demonstrated that the magnitude of the improvement was highly dependant on the LV pacing site. The coronary sinus approach rarely offers more than 1 or 2 potential pacing sites. Resynchronisation using a transeptal approach to pace the left ventricle on the cardiology has been shown feasible on small series. We therefore would like to compare these two approached in a randomised prospective study to confirm the hypotheses that endocardial LV pacing by offering multiple choices for the pacing sites reduces the number of non responders and is associated with greater hemodynamic benefit when compared to the conventional coronary sinus approach.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable heart-failure
Started Mar 2011
Longer than P75 for not_applicable heart-failure
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
December 8, 2010
CompletedFirst Posted
Study publicly available on registry
December 15, 2010
CompletedStudy Start
First participant enrolled
March 3, 2011
CompletedPrimary Completion
Last participant's last visit for primary outcome
January 1, 2015
CompletedStudy Completion
Last participant's last visit for all outcomes
July 30, 2015
CompletedMay 14, 2026
February 1, 2022
3.8 years
December 8, 2010
May 11, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
the acute hemodynamic response judged by dP/dt max
The primary outcome will be the acute hemodynamic response of the randomized pacing modality (endocardial vs epicardial Left Ventricle pacing) as judged by the highest gain in dP/dt max
Visit 3 : implantation day, during pacing procedure
Secondary Outcomes (23)
Implant success rate
Visit 3 : implantation day, end of pacing procedure
number of left ventricular pacing sites assessed
Visit 3 : implantation day, end of pacing procedure
Pacing Procedure duration
Visit 3 : implantation day, end of pacing procedure
Per and post implantation complications rate
Visit 4 : within 7 days after pacing procedure
Post implantation echocardiography comparing spontaneous rhythm and biventricular pacing for left ventricle ejection fraction
within 7 days after pacing procedure
- +18 more secondary outcomes
Study Arms (2)
Epicardial
ACTIVE COMPARATOREndocardial
EXPERIMENTALInterventions
Cardiac resynchronization with one in the right ventricle and one in the left ventricle via a transeptal puncture. Devices used for procedure : Medtronic C304 or 6227DEF, Nykanen RF Wire, RADI PressureWire
Cardiac resynchronization with one in the right ventricle and one in the left ventricle via the coronary sinus. Devices used for procedure : RADI PressureWire, routine catheters chosen by operator
Eligibility Criteria
You may qualify if:
- Adult (aged 18 or above)
- Cardiac insufficiency of whatever cause (ischemic or non-ischemic)
- Left ventricular ejection fraction \<35%
- NYHA Class III or IV with optimal medical treatment
- QRS duration \> 120 ms
- Sinus rhythm
- Patient must have signed informed consent
- Patient must be registered in the national health care system
You may not qualify if:
- Aged under 18
- Patient with a mitral or aortic prosthesis
- Patient with contraindication to anti-coagulants
- Pregnant women
- Participation in another study
- Patient with contraindication for left ventricle catheterization by retrograde aortic approach , as a severe aortic stenosis requiring surgery, or an ascending aorta aneurism
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Cardiologic Hospital Haut l'évêque
Pessac, 33604, France
Related Publications (1)
Kitamura T, Martin R, Frontera A, Jais P. Atrial tachycardia originating from deep septum following catheter ablation for persistent atrial fibrillation. Europace. 2018 Oct 1;20(10):1590. doi: 10.1093/europace/euy060. No abstract available.
PMID: 29889232RESULT
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Pierre JAIS, MD
University Hospital Bordeaux, France
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
December 8, 2010
First Posted
December 15, 2010
Study Start
March 3, 2011
Primary Completion
January 1, 2015
Study Completion
July 30, 2015
Last Updated
May 14, 2026
Record last verified: 2022-02